@deadoc80.bsky.social @meierlabicr.bsky.social
📅 Tuesday 14th Oct 2025
⏰ 16.00 PM (GMT+1)
cassyni.com/events/QAERn...
@deadoc80.bsky.social @meierlabicr.bsky.social
📅 Tuesday 14th Oct 2025
⏰ 16.00 PM (GMT+1)
cassyni.com/events/QAERn...
⏩Read: www.nature.com/articles/s41...
🤝Result of fruitful #Collaboration w/ @deadoc80.bsky.social @labliston.bsky.social & Kellie Smith!
⏩Read: www.nature.com/articles/s41...
🤝Result of fruitful #Collaboration w/ @deadoc80.bsky.social @labliston.bsky.social & Kellie Smith!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s43...
www.nature.com/articles/s43...
doi.org/10.1038/s415... 🧪
doi.org/10.1038/s415... 🧪
We attempt to integrate the data on CD8 T cell dysfunction into a new framework of hypofunctionality in cancer and chronic infections!
www.nature.com/articles/s41...
We attempt to integrate the data on CD8 T cell dysfunction into a new framework of hypofunctionality in cancer and chronic infections!
www.nature.com/articles/s41...
📑Read here: rdcu.be/ehm67
🔥Take🏠msg: Time to move away from narrow concept of #exhausted T cells to other #hypofunctional #states! 1/6🧵
@oncodaily.bsky.social
📑Read here: rdcu.be/ehm67
🔥Take🏠msg: Time to move away from narrow concept of #exhausted T cells to other #hypofunctional #states! 1/6🧵
@oncodaily.bsky.social
🙌Kudos to @deadoc80.bsky.social & E. Guilbaud for leading this!
#CancerResearch #Immunology #immunotherapy #Oncology
www.cell.com/cancer-cell/...
🙌Kudos to @deadoc80.bsky.social & E. Guilbaud for leading this!
#CancerResearch #Immunology #immunotherapy #Oncology
www.cell.com/cancer-cell/...